Publications by authors named "Hiroki Hadano"
Article Synopsis
- The study investigates the optimal timing for intubating COVID-19 patients and the effectiveness of high-flow nasal cannula (HFNC) therapy, focusing on failure rates associated with delayed treatment.
- Researchers analyzed data from 122 patients, finding that 13.9% experienced HFNC failure, with significant differences in initial oxygenation levels between failure and non-failure groups.
- The study identifies a 10% increase in lactate dehydrogenase (LDH) and interleukin (IL)-6 levels, along with persistent SARS-CoV-2 RNAemia, as indicators of higher risk for HFNC failure, emphasizing the importance of early intervention.
Although adverse events related to extracorporeal membrane oxygenation have been reported, epidemiological data on life-threatening events are insufficient to study the causes of such adverse events. Data from the Japan Council for Quality Health Care database were retrospectively analyzed. The adverse events extracted from this national database included events associated with extracorporeal membrane oxygenation reported between January 2010 and December 2021.
View Article and Find Full Text PDFRationale: Simple liver cysts are common, and usually benign and asymptomatic, requiring little to no treatment. Liver cysts with biliary communication, however, are rare and require effective treatment to avoid recurrence.
Patient Concerns: A 70-year-old woman with breast cancer visited our hospital for treatment.